Insider ownership feed
Showing Forms 3/4/5 accepted since 02 Jun 2026. Each row keeps issuer, reporting owner, reported value, role, and SEC evidence together.
Recent insider signals
Use the card actions for issuer context, owner profile, and SEC evidence.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Form 4 insider conviction
Role, issuer, transaction value, repeat activity, and SEC evidence.
Fresh reports
19,838
Forms 3, 4, and 5 filed in the current review window.
Visible buy/sell mix
0/3
Positive/negative net value among the preview cards.
Visible net value
-$7,894,668
Directional preview only; verify transaction rows and footnotes.
Newest evidence
12 Jun 2026
Use recency to separate fresh activity from stale insider stories.
Signal checks
positive net value and transaction code
multiple insiders or repeated filings
director, officer, or 10% owner context
issuer facts, 13D/G stakes, and 13F holders
SEC-verifiable Form 4 path
Open the filing, then follow the insider, issuer, or related ownership context.
Jason Aryeh filed Form 4 for LIGAND PHARMACEUTICALS INC (LGND). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Mike Klonne filed Form 4 for XPEL, Inc. (XPEL). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
John L. Lamattina filed Form 4 for LIGAND PHARMACEUTICALS INC (LGND). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Stacy L. Bogart filed Form 4 for XPEL, Inc. (XPEL). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
James Edgemond filed Form 4 for UNITED THERAPEUTICS Corp (UTHR). Role/context: CFO AND TREASURER. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
David R. Silverman filed Form 4 for Weave Communications, Inc. (WEAV). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
| Security | Issuer | Reporting owner / CIK | Reported value | Report date | Actions |
|---|---|---|---|---|---|
| LGND | LIGAND PHARMACEUTICALS INC | Jason Aryeh CIK 0001376960 | -$1,250,000 | 05 Jun 2026 | |
| XPEL | XPEL, Inc. | Mike Klonne CIK 0001783900 | $0 | 10 Jun 2026 | |
| LGND | LIGAND PHARMACEUTICALS INC | John L. Lamattina CIK 0001216074 | -$1,151,774 | 10 Jun 2026 | |
| XPEL | XPEL, Inc. | Stacy L. Bogart CIK 0001476342 | $0 | 10 Jun 2026 | |
| UTHR | UNITED THERAPEUTICS Corp | James Edgemond CIK 0001636178 | -$5,492,894 | 11 Jun 2026 | |
| WEAV | Weave Communications, Inc. | David R. Silverman CIK 0001894801 | $0 | 10 Jun 2026 | |
| CTRN | Citi Trends Inc | Chaoyang (charles) Liu CIK 0002027751 | $0 | 10 Jun 2026 | |
| UTHR | UNITED THERAPEUTICS Corp | Martine A. Rothblatt CIK 0001106578 | -$5,217,684 | 11 Jun 2026 | |
| FMAO | FARMERS & MERCHANTS BANCORP INC | Andrew J. Briggs CIK 0001763764 | -$170,790 | 11 Jun 2026 | |
| CTRN | Citi Trends Inc | Margaret L. Jenkins CIK 0001229332 | $0 | 10 Jun 2026 | |
| CTRN | Citi Trends Inc | Benjamin Taylor Faw CIK 0002105018 | $0 | 19 Feb 2026 | |
| HTLD | HEARTLAND EXPRESS INC | David P. Spalding CIK 0001193793 | +$31,380 | 10 Jun 2026 | |
| PRAX | Praxis Precision Medicines, Inc. | Stuart A. Arbuckle CIK 0001557290 | $0 | 10 Jun 2026 | |
| PRAX | Praxis Precision Medicines, Inc. | Jeffrey Chodakewitz CIK 0001610876 | $0 | 10 Jun 2026 | |
| PRAX | Praxis Precision Medicines, Inc. | William D. Young CIK 0001217420 | $0 | 10 Jun 2026 | |
| PRAX | Praxis Precision Medicines, Inc. | Jill DeSimone CIK 0001930479 | $0 | 10 Jun 2026 | |
| PRAX | Praxis Precision Medicines, Inc. | Merit Ester Cudkowicz CIK 0001856299 | $0 | 10 Jun 2026 | |
| FNB | FNB CORP/PA/ | Gary L. Guerrieri CIK 0001438642 | -$352,070 | 12 Jun 2026 | |
| PRAX | Praxis Precision Medicines, Inc. | Dean J. Mitchell CIK 0001199297 | $0 | 10 Jun 2026 | |
| PRAX | Praxis Precision Medicines, Inc. | Jeffrey B. Kindler CIK 0001174454 | $0 | 10 Jun 2026 | |
| PRAX | Praxis Precision Medicines, Inc. | Gregory Norden CIK 0001405104 | $0 | 10 Jun 2026 | |
| LARK | LANDMARK BANCORP INC | Jim Lewis CIK 0001260150 | -$37,208 | 11 Jun 2026 | |
| CTRN | Citi Trends Inc | Cara Robinson CIK 0001890843 | $0 | 10 Jun 2026 | |
| JNJ | JOHNSON & JOHNSON | Kathryn E. Wengel CIK 0001745955 | -$2,411,500 | 11 Jun 2026 | |
| OCUL | OCULAR THERAPEUTIX, INC | Charles M. Warden CIK 0001354802 | $0 | 10 Jun 2026 | |
| MAR | MARRIOTT INTERNATIONAL INC /MD/ | J. W. Marriott Jr. CIK 0001008824 | $0 | 10 Jun 2026 | |
| OCUL | OCULAR THERAPEUTIX, INC | Adrienne L. Graves CIK 0001326192 | $0 | 10 Jun 2026 | |
| OCUL | OCULAR THERAPEUTIX, INC | Jason Shand Robins CIK 0002104600 | $0 | 10 Jun 2026 | |
| OCUL | OCULAR THERAPEUTIX, INC | Seung Suh Hong CIK 0001774271 | $0 | 10 Jun 2026 | |
| CLST | Catalyst Bancorp, Inc. | Amanda B. Quebedeaux CIK 0001885819 | $0 | 10 Jun 2026 | |
| DKNG | DraftKings Inc. | Jason Robins CIK 0001810231 | $0 | 12 Jun 2026 | |
| OSS | ONE STOP SYSTEMS, INC. | Michael Knowles CIK 0001755059 | $0 | 05 Jun 2026 | |
| DKNG | DraftKings Inc. | R. Stanton Dodge CIK 0001404430 | -$1,855,202 | 11 Jun 2026 | |
| OCUL | OCULAR THERAPEUTIX, INC | Richard L. Lindstrom MD CIK 0001242177 | $0 | 10 Jun 2026 | |
| SVV | Savers Value Village, Inc. | Robyn A. Collver CIK 0001977268 | $0 | 10 Jun 2026 | |
| OCUL | OCULAR THERAPEUTIX, INC | Merilee Raines CIK 0001023869 | $0 | 10 Jun 2026 | |
| SVV | Savers Value Village, Inc. | Brian Ames CIK 0002082151 | $0 | 10 Jun 2026 | |
| OCUL | OCULAR THERAPEUTIX, INC | Leslie J. Williams CIK 0001770465 | $0 | 10 Jun 2026 | |
| XPEL | XPEL, Inc. | John F. North CIK 0001506447 | $0 | 10 Jun 2026 | |
| SVV | Savers Value Village, Inc. | Kristy Pipes CIK 0001783568 | $0 | 10 Jun 2026 | |
| SVV | Savers Value Village, Inc. | Aina E. Konold CIK 0001796168 | $0 | 10 Jun 2026 | |
| SVV | Savers Value Village, Inc. | Susan C. OFarrell CIK 0001830049 | $0 | 10 Jun 2026 | |
| ABM | ABM INDUSTRIES INC /DE/ | Scott B. Salmirs CIK 0001618972 | -$2,317,012 | 12 Jun 2026 | |
| TRDA | Entrada Therapeutics, Inc. | Peter S. Kim CIK 0001181180 | $0 | 10 Jun 2026 | |
| KOPN | KOPIN CORP | Paul V Walsh Jr. CIK 0001362672 | $0 | 10 Jun 2026 | |
| ZETA | Zeta Global Holdings Corp. | Jeanine Silberblatt CIK 0001933918 | -$149,175 | 12 Jun 2026 | |
| TRDA | Entrada Therapeutics, Inc. | Gina Chapman CIK 0001989220 | $0 | 10 Jun 2026 | |
| PPHC | Public Policy Holding Company, Inc. | John McCallum Green CIK 0002095719 | -$32,538 | 10 Jun 2026 | |
| QURE | uniQure N.V. | Rachelle Suzanne Jacques CIK 0001772610 | -$53,931 | 10 Jun 2026 | |
| PPHC | Public Policy Holding Company, Inc. | Thomas Edward Gensemer CIK 0002095722 | -$15,779 | 10 Jun 2026 |